β¨ Medicines and Tax Notices
NEW ZEALAND GAZETTE, No. 99
9 JULY 2009
Product:
OxyContin
Active Ingredient:
Oxycodone hydrochloride 15mg equivalent to oxycodone 13.5mg
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Mundipharma New Zealand Limited
Manufacturer:
Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Product:
OxyContin
Active Ingredient:
Oxycodone hydrochloride 30mg equivalent to oxycodone 27mg
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Mundipharma New Zealand Limited
Manufacturer:
Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Dated this 3rd day of July 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go5840
Classification of Medicine
Pursuant to section 106(1) of the Medicines Act 1981, I, Mark Richards, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health, acting under delegated authority, hereby declare that:
The medicine listed in the Schedule to this notice is classified as a prescription medicine.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) preparations and admixtures containing any proportion of any substance listed in the notice.
(b) salts and esters of any substance listed in the notice.
(c) preparations or extracts of biological materials listed in the notice.
(d) salts or oxides of elements listed in the notice.
Unless specific reference is made otherwise, every reference to a medicine applies:
(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and
(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.
Schedule
Prescription Medicines
Oseltamivir; except when sold in a pharmacy between the months of May to September inclusive, or for the duration of the Influenza A (H1N1) Pandemic, by a registered pharmacist who is satisfied that the medicine is for the treatment of a consumer who is resident in New Zealand, is 12 years of age or more, and currently has symptoms of influenza; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic.
All previous declarations with respect to the classification of Oseltamivir, published in the New Zealand Gazette, 12 February 2009, No. 16, page 405 and Supplement to the New Zealand Gazette, 22 June 2009, No. 91, page 2069, are hereby revoked.
Dated this 3rd day of July 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health.
go5838
Inland Revenue
Income Tax Act 2007
Resident Withholding Tax on Interest
Cancelled certificates of exemption for the period 1/4/09 to 30/6/09
010033276 010295335 011318835 013805075
020261455 025692292 043690051 046033884
047705851 049910282 055103941 055212996
059092812 062347880 065153475 065275368
067140451 067429214 067875125 068423058
070265532 071428427 073297567 075725671
078030275 081398332 081617406 081802432
082609636 083604972 084070068 084368776
087002918 090525557 090525808 091704269
091958880 093464044 095288952 096238371
096696019 096808479 098521607 099640715
go5728
Resident Withholding Tax on Interest
Reissued certificates of exemption for the period 1/4/09 to 30/6/09
010069319 010073359 010142474 010165555
010166519 010183383 010223946 010233577
010242681 010245982 010260531 010263352
010292816 010294568 010325536 010379547
010380359 010385946 010389844 010445906
010571863 010602459 010680603 010685435
010698294 010712580 010745454 010774721
010786819 010790611 010823935 010864879
010877776 010934427 011073042 011091768
011100651 011119549 011153178 011227988
011274242 011302092 011317030 011335217
011642004 011661823 011747213 011748503
011904947 011920675 012060629 012272901
012447787 012461658 012647565 013056390
013065365 013134413 013176061 013207828
013222576 013263736 013292647 013328072
013411905 013474095 013516170 013535663
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of OxyContin
π₯ Health & Social Welfare3 July 2009
OxyContin, Oxycodone hydrochloride, Modified release tablet, Mundipharma New Zealand Limited, Bard Pharmaceuticals Limited
- MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
π₯ Classification of Oseltamivir as Prescription Medicine
π₯ Health & Social Welfare3 July 2009
Oseltamivir, Prescription medicine, Influenza A (H1N1) Pandemic, Medicines Act 1981
- MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
π° Cancelled Certificates of Exemption for Resident Withholding Tax on Interest
π° Finance & RevenueIncome Tax Act 2007, Resident Withholding Tax, Certificates of exemption, Tax exemption
π° Reissued Certificates of Exemption for Resident Withholding Tax on Interest
π° Finance & RevenueIncome Tax Act 2007, Resident Withholding Tax, Certificates of exemption, Tax exemption
NZ Gazette 2009, No 99